BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36925928)

  • 21. Effect of Adjuvant Chemotherapy after Complete Resection for Pathologic Stage IB Lung Adenocarcinoma in High-Risk Patients as Defined by a New Recurrence Risk Scoring Model.
    Jang HJ; Cho S; Kim K; Jheon S; Yang HC; Kim DK
    Cancer Res Treat; 2017 Oct; 49(4):898-905. PubMed ID: 28111426
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predictive and prognostic values of factors associated with visceral pleural involvement in resected lung adenocarcinomas.
    Zhang H; Lu C; Lu Y; Yu B; Lv F; Zhu Z
    Onco Targets Ther; 2016; 9():2337-48. PubMed ID: 27143929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study.
    Luan K; Addeo A; Flores RM; Seki N; Liu A
    J Thorac Dis; 2024 Mar; 16(3):2125-2141. PubMed ID: 38617791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant Chemotherapy Improves the Probability of Freedom From Recurrence in Patients With Resected Stage IB Lung Adenocarcinoma.
    Hung JJ; Wu YC; Chou TY; Jeng WJ; Yeh YC; Hsu WH
    Ann Thorac Surg; 2016 Apr; 101(4):1346-53. PubMed ID: 26794883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The impact of visceral pleural invasion in node-negative non-small cell lung cancer: a systematic review and meta-analysis.
    Jiang L; Liang W; Shen J; Chen X; Shi X; He J; Yang C; He J
    Chest; 2015 Oct; 148(4):903-911. PubMed ID: 25675151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Could tumor spread through air spaces benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-institutional study.
    Chen D; Wang X; Zhang F; Han R; Ding Q; Xu X; Shu J; Ye F; Shi L; Mao Y; Chen Y; Chen C
    Ther Adv Med Oncol; 2020; 12():1758835920978147. PubMed ID: 33403018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Propensity-matched analysis of adjuvant chemotherapy for completely resected Stage IB non-small-cell lung cancer patients.
    Li X; Zhang C; Sun Z; Yang F; Xiao R; Sui X; Jiang G; Zhong W; Wang J
    Lung Cancer; 2019 Jul; 133():75-82. PubMed ID: 31200832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of visceral pleural invasion in the stage pT
    Zhang X; Xie J; Hu S; Peng W; Xu B; Li Y; Li C
    Curr Probl Cancer; 2021 Feb; 45(1):100640. PubMed ID: 32828574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic factors in stage IB non-small cell lung cancer according to the 8
    Moon Y; Choi SY; Park JK; Lee KY
    J Thorac Dis; 2019 Dec; 11(12):5352-5361. PubMed ID: 32030253
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of survival with adjuvant chemotherapy in patients with stage IB gastric cancer: a multicentre, observational, cohort study.
    Gao X; Li G; Deng J; Zhao L; Han W; Zhang N; Gao Y; Lu L; Wang S; Yu J; Yan J; Zhang G; Peng R; Zhang R; Fu Y; He F; Hu J; Wang W; Fan P; Si C; Gao P; Liang H; Chen H; Ji G; Shang L; Zhao Q; Zhang Z; Yang S; Wang Z; Xi H; Chen Y; Wu K; Nie Y
    Lancet Reg Health West Pac; 2024 Apr; 45():101031. PubMed ID: 38361774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Value of adjuvant chemotherapy in patients with resected stage IB solid predominant and solid non-predominant lung adenocarcinoma.
    Cao S; Teng J; Xu J; Han B; Zhong H
    Thorac Cancer; 2019 Feb; 10(2):249-255. PubMed ID: 30561142
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a low risk subgroup of stage IB lung adenocarcinoma patients.
    Mizuno T; Ishii G; Nagai K; Yoshida J; Nishimura M; Mochizuki T; Kawai O; Hasebe T; Ochiai A
    Lung Cancer; 2008 Dec; 62(3):302-8. PubMed ID: 18486987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Benefit of Postoperative Chemotherapy in Micropapillray or Solid Predominant Pattern in Stage IB Lung Adenocarcinoma: A Systematic Review and Meta-Analysis.
    Xu C; Zhu K; Chen D; Ruan Y; Jin Z; Qiu H; Chen B; Shen J
    Front Surg; 2021; 8():795921. PubMed ID: 34993229
    [No Abstract]   [Full Text] [Related]  

  • 35. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.
    Strauss GM; Herndon JE; Maddaus MA; Johnstone DW; Johnson EA; Harpole DH; Gillenwater HH; Watson DM; Sugarbaker DJ; Schilsky RL; Vokes EE; Green MR
    J Clin Oncol; 2008 Nov; 26(31):5043-51. PubMed ID: 18809614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benefit of adjuvant chemotherapy for patients with stage IB non-small cell lung cancer: a systematic review and meta-analysis.
    Wang X; Chen D; Wen J; Mao Y; Zhu X; Fan M; Chen Y
    Ann Transl Med; 2021 Sep; 9(18):1430. PubMed ID: 34733982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adjuvant chemotherapy for elderly patients with non-small-cell lung cancer.
    Yamanashi K; Okumura N; Yamamoto Y; Takahashi A; Nakashima T; Matsuoka T; Kameyama K
    Asian Cardiovasc Thorac Ann; 2017 Jun; 25(5):371-377. PubMed ID: 28592139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Visceral pleura invasion by non-small cell lung cancer: an underrated bad prognostic factor.
    Manac'h D; Riquet M; Medioni J; Le Pimpec-Barthes F; Dujon A; Danel C
    Ann Thorac Surg; 2001 Apr; 71(4):1088-93. PubMed ID: 11308141
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of adjuvant chemotherapy in stage IB non-small-cell lung cancer: an analysis of 112 consecutively treated patients.
    Dediu M; Ion O; Ion R; Alexandru A; Median D; Gal C; Horvat T; Motas C; Motas N
    J BUON; 2012; 17(2):317-22. PubMed ID: 22740212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant chemotherapy for early stage endometrioid ovarian carcinoma: An analysis of the National Cancer Data Base.
    Nasioudis D; Latif NA; Simpkins F; Cory L; Giuntoli RL; Haggerty AF; Morgan MA; Ko EM
    Gynecol Oncol; 2020 Feb; 156(2):315-319. PubMed ID: 31839340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.